Clinical trial
Efficacy of Transcranial Static Magnetic Field Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis (ALS).
NCT06834269 is registered in ClinicalTrials.gov with Campus Bio-Medico University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Transcranial Static Magnetic Field Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis (ALS).
- Lead sponsor
- Campus Bio-Medico University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 2, 2024
- Completion date
- December 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amyotrophic lateral sclerosis (als)